SCHEMBL4617050

SCHEMBL4617050

Cc1ccc(S(=O)(=O)c2ccc(F)cc2)cc1S(=O)(=O)NCCc1ccncc1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SFRP1 Q8N474 1/20 0.67
HTT P42858 6/20 0.65
PKM P14618 1/20 0.65
MAPK1 P28482 1/20 0.65
ALDH1A1 P00352 5/20 0.58
LMNA P02545 5/20 0.55
SMN1; SMN2 Q16637 4/20 0.55
MEN1 O00255 2/20 0.54
KMT2A Q03164 2/20 0.54
L3MBTL1 Q9Y468 1/20 0.54
TSHR P16473 1/20 0.52
TDP1 Q9NUW8 2/20 0.51
TAAR1 Q96RJ0 1/20 0.51
USP2 O75604 1/20 0.48
NPC1 O15118 1/20 0.48
RAB9A P51151 1/20 0.48
CYP1A2 P05177 1/20 0.46
POLB P06746 1/20 0.46
CYP2D6 P10635 1/20 0.46
CYP2C19 P33261 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4618887 0.92 SFRP1 (0.75) SFRP1HTTPKMMAPK1ALDH1A1
SCHEMBL6103353 0.90 SFRP1 (0.84) SFRP1HTTPKMMAPK1ALDH1A1
SCHEMBL4617746 0.88 SFRP1 (0.70) SFRP1HTTPKMMAPK1ALDH1A1
SCHEMBL4619649 0.88 SFRP1 (0.70) SFRP1HTTPKMMAPK1ALDH1A1
SCHEMBL6101465 0.88 SFRP1 (0.86) SFRP1HTTALDH1A1L3MBTL1TDP1
SCHEMBL4617285 0.87 SFRP1 (0.84) SFRP1HTTPKMMAPK1ALDH1A1
SCHEMBL4618849 0.86 SFRP1 (0.67) SFRP1ALDH1A1LMNAMEN1KMT2A
SCHEMBL4616020 0.86 SFRP1 (0.67) SFRP1ALDH1A1LMNAMEN1KMT2A
SCHEMBL6101322 0.86 SFRP1 (0.67) SFRP1HTTPKMMAPK1ALDH1A1
SCHEMBL6101732 0.86 SFRP1 (0.67) SFRP1ALDH1A1MEN1KMT2ATDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1879859-A2 DIARYLSULFONE SULFONAMIDES AND USE THEROF Wyeth a Corporation of the State of Delaware (US) 2008-01-23 EP claimed
US-20060276464-A1 Diarylsulfone sulfonamides and use thereof WYETH (US) 2006-12-07 US claimed
WO-2006124875-A2 DIARYLSULFONE SULFONAMIDES AND USE THEROF WYETH (US) 2006-11-23 WO claimed
EP-1879859-A2 DIARYLSULFONE SULFONAMIDES AND USE THEROF Wyeth a Corporation of the State of Delaware (US) 2008-01-23 EP disclosed
US-20060276464-A1 Diarylsulfone sulfonamides and use thereof WYETH (US) 2006-12-07 US disclosed
WO-2006124875-A2 DIARYLSULFONE SULFONAMIDES AND USE THEROF WYETH (US) 2006-11-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060276464-A1 Diarylsulfone sulfonamides and use thereof SFRP1, SOS1, FZD7 SFRP1 1/4885HTT 4703/4885PKM 4493/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.